BR0315300A - Ungulados transgênicos tendo atividade de proteìna priÈnica reduzida e seus usos - Google Patents
Ungulados transgênicos tendo atividade de proteìna priÈnica reduzida e seus usosInfo
- Publication number
- BR0315300A BR0315300A BR0315300-2A BR0315300A BR0315300A BR 0315300 A BR0315300 A BR 0315300A BR 0315300 A BR0315300 A BR 0315300A BR 0315300 A BR0315300 A BR 0315300A
- Authority
- BR
- Brazil
- Prior art keywords
- protein activity
- reduced
- cattle
- transgenic ungulates
- prion protein
- Prior art date
Links
- 230000009261 transgenic effect Effects 0.000 title abstract 4
- 102000029797 Prion Human genes 0.000 title abstract 3
- 108091000054 Prion Proteins 0.000 title abstract 3
- 230000004952 protein activity Effects 0.000 title abstract 3
- 241000283690 Bos taurus Species 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 abstract 1
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42505602P | 2002-11-08 | 2002-11-08 | |
US50690103P | 2003-09-26 | 2003-09-26 | |
PCT/US2003/035720 WO2004044156A2 (en) | 2002-11-08 | 2003-11-10 | Transgenic ungulates having reduced prion protein activity and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0315300A true BR0315300A (pt) | 2005-08-30 |
Family
ID=32314569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0315300-2A BR0315300A (pt) | 2002-11-08 | 2003-11-10 | Ungulados transgênicos tendo atividade de proteìna priÈnica reduzida e seus usos |
Country Status (12)
Country | Link |
---|---|
US (2) | US7429690B2 (pt) |
EP (1) | EP1563084A4 (pt) |
JP (1) | JP2006505291A (pt) |
KR (1) | KR20050093761A (pt) |
AU (2) | AU2003290689A1 (pt) |
BR (1) | BR0315300A (pt) |
CA (1) | CA2502490A1 (pt) |
IL (1) | IL206781A0 (pt) |
MX (1) | MXPA05004870A (pt) |
NZ (1) | NZ539459A (pt) |
RU (1) | RU2384059C2 (pt) |
WO (1) | WO2004044156A2 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7074983B2 (en) * | 1999-11-19 | 2006-07-11 | Kirin Beer Kabushiki Kaisha | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin |
AU1777301A (en) * | 1999-11-19 | 2001-05-30 | Hematech, Llc | Production of ungulates, preferably bovines that produce human immunoglobulins |
US7820878B2 (en) * | 1999-11-19 | 2010-10-26 | Kyowa Hakko Kirin Co., Ltd. | Production of ungulates, preferably bovines that produce human immunoglobulins |
US7414170B2 (en) * | 1999-11-19 | 2008-08-19 | Kirin Beer Kabushiki Kaisha | Transgenic bovines capable of human antibody production |
US7491534B2 (en) * | 2000-12-22 | 2009-02-17 | Kirin Holdings Kabushiki Kaisha | Methods for altering cell fate to generate T-cells specific for an antigen of interest |
NZ539459A (en) * | 2002-11-08 | 2009-02-28 | Kirin Pharma Kk | Transgenic ungulates having reduced prion protein activity and uses thereof |
JP2007533328A (ja) * | 2004-04-22 | 2007-11-22 | キリンホールディングス株式会社 | トランスジェニック動物及びその用途 |
CA2958259C (en) | 2004-10-22 | 2020-06-30 | Revivicor, Inc. | Ungulates with genetically modified immune systems |
US20090061485A1 (en) * | 2004-12-22 | 2009-03-05 | Chugai Seiyaku Kabushiki Kaisha | Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited |
KR100710008B1 (ko) * | 2006-02-02 | 2007-04-23 | 충남대학교산학협력단 | Streptolysin O의 체세포 처리에 의한 복제효율 증진 방법 |
WO2010051288A1 (en) | 2008-10-27 | 2010-05-06 | Revivicor, Inc. | Immunocompromised ungulates |
US9528124B2 (en) | 2013-08-27 | 2016-12-27 | Recombinetics, Inc. | Efficient non-meiotic allele introgression |
US10920242B2 (en) | 2011-02-25 | 2021-02-16 | Recombinetics, Inc. | Non-meiotic allele introgression |
EP2734552A1 (en) | 2011-07-22 | 2014-05-28 | CSL Behring GmbH | Inhibitory anti -factor xii/xiia monoclonal antibodies and their uses |
KR101662734B1 (ko) * | 2012-11-08 | 2016-10-06 | 한국생명공학연구원 | 스트렙토라이신 o의 처리에 의한 형질전환 동물의 생산성 향상 방법 |
JP5771240B2 (ja) * | 2013-06-21 | 2015-08-26 | 全国農業協同組合連合会 | 免疫不全ブタ |
WO2020146886A1 (en) * | 2019-01-11 | 2020-07-16 | GlycoScience Research, Inc. | Treatment of neurodegenerative disease with ovine gm1 gangliosidosis gm1 ganglioside |
CN116194475A (zh) | 2020-08-31 | 2023-05-30 | Sab有限责任公司 | 对冠状病毒蛋白具有特异性的有蹄类动物源性多克隆免疫球蛋白和其用途 |
Family Cites Families (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847081A (en) | 1984-07-18 | 1989-07-11 | W. R. Grace & Co.-Conn. | Synthetic bovine parainfluenza viral proteins |
CA1293460C (en) | 1985-10-07 | 1991-12-24 | Brian Lee Sauer | Site-specific recombination of dna in yeast |
US4959384A (en) * | 1985-10-24 | 1990-09-25 | Norwich Eaton Pharmaceuticals, Inc. | Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders |
US4797356A (en) | 1985-12-02 | 1989-01-10 | Konishiroku Photo Industries, Co., Ltd | Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays |
US4994384A (en) | 1986-12-31 | 1991-02-19 | W. R. Grace & Co.-Conn. | Multiplying bovine embryos |
US5470560A (en) | 1987-01-20 | 1995-11-28 | Genentech, Inc. | Method for evaluating immunogenicity |
EP0832981A1 (en) | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
US5346990A (en) | 1987-04-08 | 1994-09-13 | Cytogam, Inc. | Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
US5021244A (en) | 1988-12-06 | 1991-06-04 | Cytogam, Inc. | Sex-associated membrane antibodies and their use for increasing the probability that offspring will be of a desired sex |
US5057420A (en) | 1987-06-05 | 1991-10-15 | Granada Biosciences, Inc. | Bovine nuclear transplantation |
US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
US5213979A (en) | 1987-12-30 | 1993-05-25 | W. R. Grace & Co.-Conn. | In vitro culture of bovine embryos |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
AU649407B2 (en) | 1989-09-21 | 1994-05-26 | Infigen, Inc. | Enhanced gene expression in response to lactation signals |
US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
US5652373A (en) | 1990-01-15 | 1997-07-29 | Yeda Research And Development Co. Ltd. | Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems |
DE4000939A1 (de) | 1990-01-15 | 1991-07-18 | Brem Gottfried Prof Dr Dr | Verfahren zur antikoerpergewinnung |
AU7174791A (en) | 1990-01-26 | 1991-08-21 | Baylor College Of Medicine | Mutated promoter region from chicken skeletal alpha-actin gene |
US5160312A (en) | 1990-02-09 | 1992-11-03 | W. R. Grace & Co.-Conn. | Cryopreservation process for direct transfer of embryos |
US5614396A (en) | 1990-06-14 | 1997-03-25 | Baylor College Of Medicine | Methods for the genetic modification of endogenous genes in animal cells by homologous recombination |
US5096822A (en) | 1990-07-26 | 1992-03-17 | W. R. Grace & Co.- Conn. | Bovine embryo medium |
US5453366A (en) | 1990-07-26 | 1995-09-26 | Sims; Michele M. | Method of cloning bovine embryos |
US5639373A (en) * | 1995-08-11 | 1997-06-17 | Zenon Environmental Inc. | Vertical skein of hollow fiber membranes and method of maintaining clean fiber surfaces while filtering a substrate to withdraw a permeate |
US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
EP0814159B1 (en) | 1990-08-29 | 2005-07-27 | GenPharm International, Inc. | Transgenic mice capable of producing heterologous antibodies |
US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
AU664976B2 (en) | 1990-08-29 | 1995-12-14 | Gene Pharming Europe Bv | Homologous recombination in mammalian cells |
US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5679977A (en) * | 1990-09-24 | 1997-10-21 | Tessera, Inc. | Semiconductor chip assemblies, methods of making same and components for same |
WO1992015694A1 (en) | 1991-03-08 | 1992-09-17 | The Salk Institute For Biological Studies | Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
AU2515992A (en) | 1991-08-20 | 1993-03-16 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
AU2778992A (en) | 1991-10-07 | 1993-05-03 | Idaho Research Foundation Inc., The | Genetic construct for selection of homologous recombinants on a single selective medium |
ATE288484T1 (de) * | 1991-11-14 | 2005-02-15 | Charles Weissmann | Transgene nicht-menschliche tiere ohne prionprotein |
WO1993015191A1 (en) | 1992-01-24 | 1993-08-05 | Life Technologies, Inc. | Modulation of enzyme activities in the in vivo cloning of dna |
US5843643A (en) | 1992-02-21 | 1998-12-01 | Ratner; Paul L. | Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid |
US5763240A (en) | 1992-04-24 | 1998-06-09 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
NZ255101A (en) | 1992-07-24 | 1997-08-22 | Cell Genesys Inc | A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor |
US5480772A (en) | 1993-02-03 | 1996-01-02 | Brandeis University | In vitro activation of a nucleus |
US5496720A (en) | 1993-02-10 | 1996-03-05 | Susko-Parrish; Joan L. | Parthenogenic oocyte activation |
JP2677154B2 (ja) | 1993-03-08 | 1997-11-17 | 日東紡績株式会社 | 総ケトン体の測定方法および測定試薬 |
EP0689597A4 (en) | 1993-03-16 | 1998-10-21 | Austin Research Inst | USE OF PIG GAL-g (a) (1,3) GALACTOSYL TRANSFERASE FOR XENOGENE THERAPIES |
WO1995015972A1 (en) | 1993-12-09 | 1995-06-15 | Thomas Jefferson University | Compounds and methods for site-directed mutations in eukaryotic cells |
US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
US5849991A (en) | 1994-01-27 | 1998-12-15 | Bresatch Limited | Mice homozygous for an inactivated α 1,3-galactosyl transferase gene |
US5639940A (en) | 1994-03-03 | 1997-06-17 | Pharmaceutical Proteins Ltd. | Production of fibrinogen in transgenic animals |
JPH09509847A (ja) | 1994-03-09 | 1997-10-07 | アボツト・ラボラトリーズ | 人乳化乳 |
US6204431B1 (en) | 1994-03-09 | 2001-03-20 | Abbott Laboratories | Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk |
DE69535752D1 (de) | 1994-04-13 | 2008-06-26 | Biotransplant Inc | Alpha(1,3)galactosyltransferase-negatives schwein |
US5565186A (en) * | 1994-05-13 | 1996-10-15 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
US5789655A (en) | 1994-05-13 | 1998-08-04 | The Regents Of The University Of California | Transgenic animals expressing artificial epitope-tagged proteins |
EP0764207A1 (en) | 1994-06-03 | 1997-03-26 | Diacrin, Inc. | Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants |
US5583016A (en) | 1994-07-07 | 1996-12-10 | Geron Corporation | Mammalian telomerase |
US5876979A (en) | 1994-07-07 | 1999-03-02 | Cold Spring Harbor Laboratory | RNA component of mouse, rat, Chinese hamster and bovine telomerase |
JP3432052B2 (ja) * | 1994-09-02 | 2003-07-28 | キヤノン株式会社 | インクジェット記録装置 |
US5780296A (en) | 1995-01-17 | 1998-07-14 | Thomas Jefferson University | Compositions and methods to promote homologous recombination in eukaryotic cells and organisms |
US5780009A (en) | 1995-01-20 | 1998-07-14 | Nexia Biotechnologies, Inc. | Direct gene transfer into the ruminant mammary gland |
US6091001A (en) * | 1995-03-29 | 2000-07-18 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
JP4312259B2 (ja) | 1995-04-27 | 2009-08-12 | アムジェン フレモント インク. | 免疫したゼノマウス(XenoMouse)に由来するヒト抗体 |
US5776744A (en) | 1995-06-07 | 1998-07-07 | Yale University | Methods and compositions for effecting homologous recombination |
AU723003C (en) | 1995-08-04 | 2004-01-29 | General Hospital Corporation, The | Transgenic swine and swine cells having human HLA genes |
US5952222A (en) | 1995-08-04 | 1999-09-14 | The Board Of Trustees Of The University Of Arkansas | Functional enucleation of bovine oocytes |
US5733730A (en) | 1995-08-25 | 1998-03-31 | The Rockefeller University | Telomere repeat binding factor and diagnostic and therapeutic use thereof |
ATE352613T1 (de) | 1995-08-29 | 2007-02-15 | Kirin Brewery | Chimäres tier und methode zu dessen herstellung |
GB9517779D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5695977A (en) | 1995-08-31 | 1997-12-09 | Genetic Information Research Institute | Site directed recombination |
GB9517780D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5801030A (en) | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
US6166288A (en) | 1995-09-27 | 2000-12-26 | Nextran Inc. | Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor |
US6133503A (en) | 1995-10-31 | 2000-10-17 | The Regents Of The University Of California | Mammalian artificial chromosomes and methods of using same |
US5679523A (en) | 1995-11-16 | 1997-10-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method for concurrent disruption of expression of multiple alleles of mammalian genes |
US5770422A (en) | 1996-07-08 | 1998-06-23 | The Regents Of The University Of California | Human telomerase |
US6183993B1 (en) | 1996-09-11 | 2001-02-06 | The General Hospital Corporation | Complement-resistant non-mammalian DNA viruses and uses thereof |
EP2213740A1 (en) | 1996-10-01 | 2010-08-04 | The Regents of the University of Colorado | Human telomerase catalytic subunit |
CA2267220A1 (en) | 1996-10-11 | 1998-04-23 | The Texas A & M University System | Methods for the generation of primordial germ cells and transgenic animal species |
US6054632A (en) | 1996-11-15 | 2000-04-25 | New York Blood Center, Inc. | Method of making monoclonal antibodies using polymorphic transgenic animals |
CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
GB9703550D0 (en) | 1997-02-20 | 1997-04-09 | Ppl Therapeutics Scotland Ltd | Cell mediated transgenesis |
WO1998039416A1 (en) | 1997-03-06 | 1998-09-11 | Infigen, Inc. | Method of cloning animals |
US6011197A (en) | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
US5830698A (en) | 1997-03-14 | 1998-11-03 | Idec Pharmaceuticals Corporation | Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
AU1581899A (en) | 1997-10-28 | 1999-05-17 | Biotransplant Incorporated | Nuclear transfer for production of transgenic animal embryo |
AU4079799A (en) | 1998-05-15 | 1999-12-06 | Sri International | Transgenic animals produced by homologous sequence targeting |
TWI255853B (en) | 1998-08-21 | 2006-06-01 | Kirin Brewery | Method for modifying chromosomes |
US6258998B1 (en) | 1998-11-24 | 2001-07-10 | Infigen, Inc. | Method of cloning porcine animals |
CA2360549C (en) | 1999-01-13 | 2013-04-09 | Ppl Therapeutics (Scotland) Limited | Double nuclear transfer method and results thereof |
CA2362098C (en) | 1999-02-05 | 2011-10-11 | Jens-Ulrich Bulow | Human polyclonal antibodies from genetically engineered animals |
DE60043578D1 (de) | 1999-03-04 | 2010-02-04 | Revivicor Inc | Genetische veränderung von somatischen zellen und deren verwendungen |
US20020012660A1 (en) * | 1999-03-04 | 2002-01-31 | Alan Colman | Method of preparing a somatic cells for nuclear transfer |
ATE394029T1 (de) | 1999-05-06 | 2008-05-15 | Stem Cell Sciences Australia P | Verfahren der zellreprogrammierung durch herstellung eines heterokaryons |
AUPQ025999A0 (en) | 1999-05-10 | 1999-06-03 | Garelag Pty Ltd | Non enucleation and enucleation post fusion of nuclear transfer embryos |
EP1191840B1 (en) | 1999-06-04 | 2007-01-17 | Istituto Zootecnico E Caseario per La Sardegna | Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom. |
IL147179A0 (en) * | 1999-06-30 | 2002-08-14 | Advanced Cell Tech Inc | Cytoplasmic transfer to de-differentiate recipient cells |
EP1220928A2 (en) | 1999-09-30 | 2002-07-10 | Alexion Pharmaceuticals, Inc. | Compositions and methods for altering gene expression |
CA2426669A1 (en) | 1999-10-22 | 2001-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | .alpha.1-3 galactosyltransferase gene and promoter |
US7414170B2 (en) * | 1999-11-19 | 2008-08-19 | Kirin Beer Kabushiki Kaisha | Transgenic bovines capable of human antibody production |
AU1777301A (en) | 1999-11-19 | 2001-05-30 | Hematech, Llc | Production of ungulates, preferably bovines that produce human immunoglobulins |
US7074983B2 (en) * | 1999-11-19 | 2006-07-11 | Kirin Beer Kabushiki Kaisha | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin |
AU2001247773A1 (en) * | 2000-03-24 | 2001-10-08 | University Of Massachusetts, As Represented By Its Amherst Campus | Prion-free transgenic ungulates |
EP2044839A3 (en) | 2000-08-03 | 2009-07-01 | Therapeutic Human Polyclonals, Inc. | Production of humanized antibodies in transgenic animals |
KR100882030B1 (ko) * | 2000-11-17 | 2009-02-09 | 교와 핫꼬 기린 가부시키가이샤 | 클로닝된 트랜스제닉 유제류에서 이종 (사람)면역글로블린의 발현 |
US6613695B2 (en) * | 2000-11-24 | 2003-09-02 | Asm America, Inc. | Surface preparation prior to deposition |
EP1356035B1 (en) * | 2000-12-22 | 2011-03-16 | Kyowa Hakko Kirin Co., Ltd. | Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells |
US20020108132A1 (en) * | 2001-02-02 | 2002-08-08 | Avigenics Inc. | Production of a monoclonal antibody by a transgenic chicken |
GB0107757D0 (en) | 2001-03-28 | 2001-05-16 | Gendaq Ltd | Gene regulation II |
AU2002258646A1 (en) * | 2001-03-30 | 2002-10-15 | Texas A And M University System | Transgenic animals resistant to transmissible spongiform encephalopathies |
JP2002316944A (ja) | 2001-04-17 | 2002-10-31 | Chemo Sero Therapeut Res Inst | ヒトポリクローナル抗体組成物 |
NZ539459A (en) | 2002-11-08 | 2009-02-28 | Kirin Pharma Kk | Transgenic ungulates having reduced prion protein activity and uses thereof |
JP2007533328A (ja) * | 2004-04-22 | 2007-11-22 | キリンホールディングス株式会社 | トランスジェニック動物及びその用途 |
CA2958259C (en) * | 2004-10-22 | 2020-06-30 | Revivicor, Inc. | Ungulates with genetically modified immune systems |
-
2003
- 2003-11-10 NZ NZ539459A patent/NZ539459A/en not_active IP Right Cessation
- 2003-11-10 AU AU2003290689A patent/AU2003290689A1/en not_active Abandoned
- 2003-11-10 EP EP03783271A patent/EP1563084A4/en not_active Ceased
- 2003-11-10 WO PCT/US2003/035720 patent/WO2004044156A2/en active Application Filing
- 2003-11-10 RU RU2005117629/13A patent/RU2384059C2/ru active
- 2003-11-10 US US10/705,519 patent/US7429690B2/en not_active Expired - Lifetime
- 2003-11-10 BR BR0315300-2A patent/BR0315300A/pt not_active IP Right Cessation
- 2003-11-10 JP JP2005507127A patent/JP2006505291A/ja active Pending
- 2003-11-10 MX MXPA05004870A patent/MXPA05004870A/es active IP Right Grant
- 2003-11-10 CA CA002502490A patent/CA2502490A1/en not_active Abandoned
- 2003-11-10 KR KR1020057008140A patent/KR20050093761A/ko not_active Application Discontinuation
-
2008
- 2008-09-05 US US12/231,873 patent/US7807863B2/en not_active Expired - Lifetime
-
2010
- 2010-07-04 IL IL206781A patent/IL206781A0/en unknown
- 2010-09-17 AU AU2010224312A patent/AU2010224312A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2006505291A (ja) | 2006-02-16 |
US7429690B2 (en) | 2008-09-30 |
WO2004044156A3 (en) | 2004-07-29 |
RU2384059C2 (ru) | 2010-03-20 |
CA2502490A1 (en) | 2004-05-27 |
WO2004044156A2 (en) | 2004-05-27 |
NZ539459A (en) | 2009-02-28 |
EP1563084A2 (en) | 2005-08-17 |
IL206781A0 (en) | 2010-12-30 |
US20090165154A1 (en) | 2009-06-25 |
KR20050093761A (ko) | 2005-09-23 |
RU2005117629A (ru) | 2006-01-20 |
EP1563084A4 (en) | 2006-03-01 |
MXPA05004870A (es) | 2005-11-04 |
AU2003290689A1 (en) | 2004-06-03 |
AU2010224312A1 (en) | 2010-10-14 |
US20050097627A1 (en) | 2005-05-05 |
US7807863B2 (en) | 2010-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0315300A (pt) | Ungulados transgênicos tendo atividade de proteìna priÈnica reduzida e seus usos | |
Bellaver et al. | Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats | |
Sanotra et al. | A comparison between leg problems in Danish and Swedish broiler production | |
BR0109521A (pt) | Ungulados transgênicos sem prìons | |
BR9808417A (pt) | Produto alimentìcio para animais de estimação | |
MX2007013866A (es) | Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. | |
Thomas et al. | Towards a zooarchaeology of animal ‘care’ | |
BR0206869A (pt) | método para o tratamento de um animal sofrendo de um estado doentio de disfunção imune associado com nìveis alterados de igg ou tnf-delta, composição farmacêutica para o tratamento de distúrbios auto-imunes associados com elevados igg e/ou tnf-delta ou para a potenciação de protocolos de vacina, e método para o tratamento de estado doentio associado com disfunção imune em um animal | |
ES2184865T3 (es) | Peptido para inhibir el aumento del nivel de trigliceridos en sangre einhibidor para el aumento del nivel de trigliceridos en sangre que comprende el peptido como ingrediente activo. | |
Schuurman | Microbiological safety of clinical xenotransplantation products: monitoring strategies and regulatory aspects. A commentary. | |
Greet et al. | Foot management in the foal and weanling | |
Mosbah et al. | Congenital limb deformities in some farm animals. | |
PA8459201A1 (es) | Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimiento para fabricarla | |
Thomas et al. | Ring depressions in cattle horncores as indicators of traction use–a cautionary note | |
Anz et al. | Animals as healers: A historical journey through the impact of animals on human health across the ages | |
Choate et al. | Use of hinged circular fixator constructs for the correction of crural deformities in three dogs | |
BRPI0413771A (pt) | copolìmeros de polioxipropileno/polioietileno purificados e método de preparação dos mesmos | |
Rannamäe et al. | A month in a horse’s life: healing process of a fractured third metatarsal bone from medieval Viljandi, Estonia | |
Macri et al. | Congenital absence of humerus with preaxial terminal longitudinal hemimelia and hypoplasia of the scapula in a dog: a case report. | |
Ahmed | Surgical correction of bilateral polydactyly in a dromedary camel: a case report. | |
Macri et al. | A rare case of partial paraxial radial hemimelia in a puppy | |
Klarenbeek et al. | Canine X-linked muscular dystrophy in a family of Grand Basset Griffon Vendeen dogs | |
TEKIN et al. | UNILATERAL LONGITUDINAL PREAXIAL RADIAL HEMIMELIA IN A PUPPY: A CASE REPORT | |
Cardona et al. | Rupture of the gastrocnemius muscle in a heifer Gyr in the department of Córdoba, Colombia. | |
Farhan et al. | Sacrificial Animals and their Management BeforeEid-ul-Adha |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: HEMATECH, LLC (US) , KIRIN HOLDINGS KABUSHIKI KAIS Free format text: ALTERADO DE: KIRIN BREWERY CO., LTD. |
|
B25G | Requested change of headquarter approved |
Owner name: HEMATECH, LLC (US) , KIRIN HOLDINGS KABUSHIKI KAIS Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020080142999/RJ DE 17/11/2008. |
|
B25A | Requested transfer of rights approved |
Owner name: KIRIN HOLDINGS KABUSHIKI KAISHA (JP) Free format text: TRANSFERIDO DE: HEMATECH, LLC |
|
B25A | Requested transfer of rights approved |
Owner name: KIRIN PHARMA KABUSHIKI KAISHA (JP) Free format text: TRANSFERIDO DE: KIRIN HOLDINGS KABUSHIKI KAISHA |
|
B25A | Requested transfer of rights approved |
Owner name: KYOWA HAKKO KIRIN CO., LTD. (JP) Free format text: TRANSFERIDO DE: KIRIN PHARMA KABUSHIKI KAISHA |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |